Načítá se...
Metabolomics in Diabetic Kidney Disease: Unraveling the Biochemistry of A Silent Killer
The development of new therapies for chronic diseases, such as diabetic kidney disease, will continue to be hampered by lack of sufficient biomarkers that will provide insights and will be responsive to treatment interventions. The recent application of metabolomic technologies, such as nuclear magn...
Uloženo v:
| Vydáno v: | Am J Nephrol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6581452/ https://ncbi.nlm.nih.gov/pubmed/27410520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000447954 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|